| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 260,789 | 263,647 | 256,162 | 169,157 | | Cost of Revenue | 108,449 | 114,334 | 105,372 | 54,844 | | | Gross Profit | 152,340 | 149,313 | 150,790 | 114,313 | | | Operating Expenses | | Research Development | 16,796 | 17,141 |
-
|
-
| | Selling General and Administrative | 83,782 | 86,177 | 99,850 | 80,455 | | Non Recurring |
-
|
-
| 176,150 | 93 | | Others | 8,648 | 8,591 | 8,591 | 4,966 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 43,114 | 37,404 | (133,801) | 28,799 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 431 | 386 | (276) | 1,000 | | Earnings Before Interest And Taxes | 43,545 | 37,790 | (134,077) | 29,799 | | Interest Expense | 8,804 | 8,201 | 9,419 | 3,206 | | Income Before Tax | 34,741 | 29,589 | (143,496) | 26,593 | | Income Tax Expense | 15,474 | 12,536 | (5,933) | 10,427 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 19,267 | 17,053 | (137,563) | 16,166 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 19,267 | 17,053 | (137,563) | 16,166 | | Preferred Stock And Other Adjustments | (1,544) | (671) |
-
|
-
| | | Net Income Applicable To Common Shares | $17,723 | $16,382 | ($137,563) | $16,166 |
|
0.03% Nasdaq 
Income Statement
